SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1086 These guys had been sitting on the stock for so long without any liquidity. ProDavid Israel-Rosen-3/7/2000
1085 well so much for shake out--momos got me--i exited at 12 with 1.5 points still LTK007-3/7/2000
1084finance.yahoo.com this is nice news---i doubled on PARS yesterday in the 10s andLTK007-3/7/2000
1083 Pharmos Announces Successful Completion of Phase II Head Trauma Clinical StudieMoney Mood-3/7/2000
1082 As for mortality results in phase 2. If you put 1+1. look what you get. 1.Phaseyosi s-3/7/2000
1081 Aviv hyping P2C3? As of last week he was downplaying, out of concern the hype Jesse Schulman-3/7/2000
1080 From the press release. Pharmos R&D is moving up all its pipeline. They gotyosi s-3/6/2000
1079 Gabe,is this what you are refering,it is all to the good--this taken from todayLTK007-3/6/2000
1078 <<While the following doesn't directly relate to HU211>> PharmoLTK007-3/6/2000
1077 Pharmos Corp Year Losses 11c/Shr Vs 15c Monday, March 6, 2000 07:31 P Pharmos LT-3/6/2000
1076 Pharmos Corporation 1999 Loss Narrows vs. 1998; Second Round of Financing ResulLT-3/6/2000
1075 insider selling as studied by WSJ is an inferior indicator--that's all i haLTK007-3/6/2000
1074 David What is your read on Insider selling.Gabe Fernandez-3/6/2000
1073 If the main stream print and visual media pick up the story you will have anothLT-3/6/2000
1072 Pharmos' Dexanabinol Effective in Multiple Sclerosis Animal Model; Potentialeigh aulper-3/6/2000
1071 That ground swell of buying support we talked about is doing it's thing....LT-3/6/2000
1070 some buyer came in and swooped up every available share of PARS that was at 11LTK007-3/5/2000
1069 David, Competition is on of the hardest issues - if somebody else has been doiMoney Mood-3/5/2000
1068 Look at Lancet article on Head Trauma mapinc.orgDavid Israel-Rosen-3/5/2000
1067 MS EPIDEMIOLOGY - Nationwide, there are an estimated 250,000 to 350,000 peopleleigh aulper-3/5/2000
1066 an eaiser read the competition - REPORT OF RESULTS FROM HEAD-TO-HEAD CLINIleigh aulper-3/5/2000
1065 an easier read-- tip--do not check off fixed font MARIJUANA DERIVATIVES IMPROVEleigh aulper-3/5/2000
1064 Questions for David & The Board... David, as a fellow PARSian, I certainlycm-3/5/2000
1063 <I>I do not see a significant dip in share price for a while</I> ALT-3/5/2000
1062 MS EPIDEMIOLOGY - Nationwide, there are an estimated 250,000 to 350,000 people David Israel-Rosen-3/5/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News